86 related articles for article (PubMed ID: 16949645)
1. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia.
Tava F; Luinetti O; Ghigna MR; Alvisi C; Perego M; Trespi E; Klersy C; Fratti C; Fiocca R; Solcia E
Hum Pathol; 2006 Nov; 37(11):1489-97. PubMed ID: 16949645
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of
Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
[TBL] [Abstract][Full Text] [Related]
3. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?
Sugano K; Moss SF; Kuipers EJ
Gastroenterology; 2023 Dec; 165(6):1352-1366.e1. PubMed ID: 37652306
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic Kyoto and Kimura-Takemoto Classifications Are Comparable in Predicting High-Risk Gastric Precancerous Lesions.
Nguyen DTN; Quach DT; Le QD; Vu NTH; Dang NLB; Le HM; Le NQ; Oka S; Tanaka S; Hiyama T
Digestion; 2024; 105(2):140-148. PubMed ID: 38190818
[TBL] [Abstract][Full Text] [Related]
5. CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors.
Jang B; Lee SH; Dovirak I; Kim H; Srivastava S; Teh M; Yeoh KG; So JB; Tsao SKK; Khor CJ; Ang TL; Goldenring JR
Gastric Cancer; 2024 Mar; 27(2):263-274. PubMed ID: 38221567
[TBL] [Abstract][Full Text] [Related]
6. Gastric dysplasia in random biopsies: the influence of
Ferreira AI; Lima Capela T; Macedo Silva V; Xavier S; Boal Carvalho P; Magalhães J; Cotter J
Scand J Gastroenterol; 2024; 59(2):125-132. PubMed ID: 37872792
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence for evaluating the risk of gastric cancer: reliable detection and scoring of intestinal metaplasia with deep learning algorithms.
Iwaya M; Hayashi Y; Sakai Y; Yoshizawa A; Iwaya Y; Uehara T; Kitagawa M; Fukayama M; Mori K; Ota H
Gastrointest Endosc; 2023 Dec; 98(6):925-933.e1. PubMed ID: 37392953
[TBL] [Abstract][Full Text] [Related]
8. Frequency of atypical mitosis in intestinal metaplasia of the gastric mucosa in Japanese patients.
Rubio CA; Kato Y; Kitagawa T
Jpn J Cancer Res; 1994 Mar; 85(3):284-9. PubMed ID: 8188528
[TBL] [Abstract][Full Text] [Related]
9. Gastric Cancer Risk of Intestinal Metaplasia Subtypes: A Systematic Review and Meta-Analysis of Cohort Studies.
Du S; Yang Y; Fang S; Guo S; Xu C; Zhang P; Wei W
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00402. PubMed ID: 34597278
[TBL] [Abstract][Full Text] [Related]
10. Extensive intestinal metaplasia in gastric carcinoma and in other lesions requiring surgery: a study of 3,421 gastrectomy specimens from dwellers of the Atlantic and Pacific basins.
Rubio CA; Jónasson J; Nesi G; Mandai K; Pisano R; King A; Owen D
J Clin Pathol; 2005 Dec; 58(12):1271-7. PubMed ID: 16311346
[TBL] [Abstract][Full Text] [Related]
11. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.
Pimentel-Nunes P; Libânio D; Marcos-Pinto R; Areia M; Leja M; Esposito G; Garrido M; Kikuste I; Megraud F; Matysiak-Budnik T; Annibale B; Dumonceau JM; Barros R; Fléjou JF; Carneiro F; van Hooft JE; Kuipers EJ; Dinis-Ribeiro M
Endoscopy; 2019 Apr; 51(4):365-388. PubMed ID: 30841008
[TBL] [Abstract][Full Text] [Related]
12. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review.
Spence AD; Cardwell CR; McMenamin ÚC; Hicks BM; Johnston BT; Murray LJ; Coleman HG
BMC Gastroenterol; 2017 Dec; 17(1):157. PubMed ID: 29228909
[TBL] [Abstract][Full Text] [Related]
14. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
[TBL] [Abstract][Full Text] [Related]
15. Gastric pit dysplasia in adjacent gastric mucosa in 414 gastric cancers: prevalence and characteristics.
Shin N; Jo HJ; Kim WK; Park WY; Lee JH; Shin DH; Choi KU; Kim JY; Lee CH; Sol MY; Jeon TY; Kim DW; Huh GY; Kim GH; Lauwers GY; Park DY
Am J Surg Pathol; 2011 Jul; 35(7):1021-9. PubMed ID: 21677540
[TBL] [Abstract][Full Text] [Related]
16. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia.
Filipe MI; Muñoz N; Matko I; Kato I; Pompe-Kirn V; Jutersek A; Teuchmann S; Benz M; Prijon T
Int J Cancer; 1994 May; 57(3):324-9. PubMed ID: 8168991
[TBL] [Abstract][Full Text] [Related]
17. Interobserver agreement of estimating the extent of intestinal metaplasia in patients with chronic atrophic gastritis.
Lerch JM; Pai RK; Brown I; Gill AJ; Jain D; Kővári B; Kushima R; Sheahan K; Slavik T; Srivastava A; Lauwers GY; Langner C
Virchows Arch; 2022 Jun; 480(6):1277-1281. PubMed ID: 34904185
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer: lessons learned from high-incidence geographic regions.
Abengozar R; Sharma A; Sharma R
J Gastrointest Oncol; 2021 Jul; 12(Suppl 2):S350-S360. PubMed ID: 34422399
[TBL] [Abstract][Full Text] [Related]
19. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M
Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867
[TBL] [Abstract][Full Text] [Related]
20. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
